BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 622062)

  • 21. Angiotensin converting enzyme inhibitors and quality of life: the European trial.
    Hill JF; Bulpitt CJ; Fletcher AE
    J Hypertens Suppl; 1985 Nov; 3(2):S91-4. PubMed ID: 3003305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiclinic evaluation of the antihypertensive effect of a methyldopa, hydrochlorothiazine, and amiloride combination.
    Moncloa F; Hwang IK; Muccilli AC
    Clin Ther; 1980; 3(3):168-75. PubMed ID: 7006811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihypertensive therapy in elderly patients. Pilot trial of the European Working Party on High Blood Pressure in the Elderly.
    Amery A; Berthaux P; Birkenhäger W; Bulpitt C; Clement D; De Shaepdryver A; Dollery C; Ernould H; Fagard R; Forette F; Hellemans J; Kho T; Lund-Johansen P; Meurice J; Pierquin L
    Gerontology; 1977; 23(6):426-37. PubMed ID: 330322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in the ratio of plasma to intersitiial fluid volume during long-term antihypertensive therapy.
    Leth A; Ibsen H
    J Lab Clin Med; 1976 May; 87(5):781-91. PubMed ID: 1270888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse treatment effects in the trial of the European Working Party on High Blood Pressure in the Elderly.
    Fletcher AE
    Am J Med; 1991 Mar; 90(3A):42S-44S. PubMed ID: 2006659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antihypertensive action of drug combination: Timolol, hydralazine, hydrochlorothiazide and triamterene.
    Pörsti P; Jalonen K; Ryysy L; Toivonen T; Viherkoski M
    Ann Clin Res; 1981 Feb; 13(1):6-10. PubMed ID: 7018363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of the efficacy and tolerability of a fixed dose combination of captopril (CPT) 50 mg and hydrochlorothiazide (HCTZ) 15 mg in the elderly].
    Antonicelli R; Raffaelli S; Bossini A; Paciaroni E; Zingaretti P; Botta GF
    Riv Eur Sci Med Farmacol; 1989 Apr; 11(2):155-61. PubMed ID: 2678309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlations between subjective compliance, objective compliance, and factors determining compliance in geriatric hypertensive patients treated with triamterene and hydrochlorothiazide.
    Oelzner S; Brandstädt A; Hoffmann A
    Int J Clin Pharmacol Ther; 1996 Jun; 34(6):236-42. PubMed ID: 8793610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-response curves in antihypertensive combination therapy: results of a controlled clinical trial.
    Letzel H; Bluemner E
    J Hypertens Suppl; 1990 Sep; 8(4):S83-6. PubMed ID: 2258790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of arterial hypertension in elderly patients].
    Halawa B
    Wiad Lek; 1981 Aug; 34(16):1357-62. PubMed ID: 7041432
    [No Abstract]   [Full Text] [Related]  

  • 32. European working party on high blood pressure in elderly (EWPHE): organization of a double-blind multicentre trial on antihypertensive therapy in elderly patients.
    Amery A; De Schaepdrijver A
    Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():71s-3. PubMed ID: 4593570
    [No Abstract]   [Full Text] [Related]  

  • 33. Effectiveness of twice-daily dosage of methyldopa in essential hypertension.
    Hollifield JW; Slaton PE
    J Tenn Med Assoc; 1978 May; 71(5):337-40. PubMed ID: 661299
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
    Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
    Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of guanethidine and methyldopa in essential hypertension: a controlled study.
    Glazer N
    Curr Ther Res Clin Exp; 1975 Mar; 17(3):249-56. PubMed ID: 805019
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative efficacy and bioequivalence of a brand-name and a generic triamterene-hydrochlorothiazide combination product.
    Sharoky M; Perkal M; Tabatznik B; Cane RC; Costello K; Goodwin P
    Clin Pharm; 1989 Jul; 8(7):496-500. PubMed ID: 2752698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methyldopa: an agent for the treatment of older patients with isolated systolic hypertension.
    Vaicaitis JS
    Clin Ther; 1984; 6(4):451-6. PubMed ID: 6467278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SYST-EUR multicentre trial on the treatment of isolated systolic hypertension in the elderly: first interim report.
    Slovick DI; Amery A; Birkenhager W; Bulpitt CJ; Cox J; de Leeuw P; de Cort P; Fagard R; Fletcher A; Forette F
    J Hum Hypertens; 1993 Apr; 7(2):201-3. PubMed ID: 8510096
    [No Abstract]   [Full Text] [Related]  

  • 39. [Arterial hypertension and hemorheology: the effects of triamterene and hydrochlorothiazide].
    Spürk P; Gerlach A; Angelkort B
    Med Klin (Munich); 1990 Jul; 85(7):425-8. PubMed ID: 2385208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive therapy in patients above age 60. Third interim report of the European Working Party on High blood pressure in Elderly (EWPHE).
    Amery A; Berthaux P; Birkenhäger W; Boel A; Brixko P; Bulpitt C; Clement D; Deruyttere M; de Schaepdryver A; Dollery C; Fagard R; Forette F; Henry JF; Hellemans J; Laaser U; Lund-Johansen P; MacFarlane J; Maling T; Mutsers A; Nissinen A; Ohn OH; Pelemans J; Suchettkaye AI; Tuomilehto J; Willems J
    Acta Cardiol; 1978; 33(2):113-34. PubMed ID: 356497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.